Over 1.77 Crore COVID Vaccine Doses Still Available With States, UTs: Health Ministry Covaxin and Covishield (Jagran English)

More than 1.77 crore COVID Vaccine doses (1,77,67,850) are still available with the states and union territories (UTs) to be administered, and around seven lakh more jabs will supplied to them in the next three days, the Health Ministry said on Tuesday (25 May).

In a statement, the ministry said that the Centre has so far provided, both through the free of cost category and through direct state procurement category, more than 21.89 crore vaccine doses (21,89,69,250) to states and UTs.

"Of this, the total consumption,including wastages is 19,93,39,750 doses (as per data available at 8 AM today)," it said.

"More than 1.77 crore COVID Vaccine doses (1,77,67,850) are still available with the states/UTs to be administered," the statement added.

Furthermore, seven lakh vaccine doses are in the pipeline and will be received by the states and UTs within the next three days,

Under the 'Liberalised and Accelerated Phase-3 Strategy of Covid-19 Vaccination', which started from 1 May, every month 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by the Centre and will be supplied free of cost to states and UTs.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement